NASDAQ:AVXL

Anavex Life Sciences Stock Insider Trading

Healthcare > Biotechnology

Buy AVXL

*Your capital is at risk

$2.65

-0.140 (-5.03%)

At Close: Jun 03, 2026

Anavex Life Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 54.54. In total, the insiders bought 9.05M and sold 1.56M AVXL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	54.54
● Buy	9.05M shares
● Sell	1.56M shares
90% Buy Activity Negligible or No Correlation
Buy Signal High Confidence May 04, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 54.54. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (90% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 04, 2026 Buy	Options (Right to Buy)	Kellmeyer Terrie Interim CEO	CEO / President	46 668 Value: $336.5K
May 04, 2026 Buy	Options (Right to Buy)	Kellmeyer Terrie Interim CEO	CEO / President	7 500 Value: $40.2K
May 04, 2026 Buy	Options (Right to Buy)	Kellmeyer Terrie Interim CEO	CEO / President	50 000 Value: $429.0K
Feb 23, 2026 Buy	Common Stock J-Other	Paeger Axel	Director	0 Value: $0
Jan 06, 2026 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $1.07M
Jan 06, 2026 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	12 500 Value: $107.3K
Oct 02, 2025 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	12 500 Value: $67.0K
Oct 02, 2025 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $670.0K
Oct 02, 2025 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $670.0K
Oct 02, 2025 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	12 500 Value: $67.0K
Sep 11, 2025 Buy	Common Stock M-Exempt	Missling Christopher U President And CEO	CEO / President	187 500 Value: $945.0K
Sep 11, 2025 Sell	Common Stock F-InKind	Missling Christopher U President And CEO	CEO / President	145 048 Value: $1.39M
Sep 11, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Missling Christopher U President And CEO	CEO / President	187 500 Value: $945.0K
Sep 11, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Missling Christopher U President And CEO	CEO / President	187 500 Value: $945.0K
Sep 11, 2025 Sell	Common Stock F-InKind	Missling Christopher U President And CEO	CEO / President	145 048 Value: $1.39M
Sep 11, 2025 Buy	Common Stock M-Exempt	Missling Christopher U President And CEO	CEO / President	187 500 Value: $945.0K
Aug 20, 2025 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	12 500 Value: $107.3K
Aug 20, 2025 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $1.07M
Aug 20, 2025 Buy	Stock Option (Right to Buy) A-Award	Missling Christopher U President And CEO	CEO / President	125 000 Value: $1.07M
Aug 20, 2025 Buy	Stock Option (Right to Buy) A-Award	Boenisch Sandra Pfo & Treasurer	Officer	12 500 Value: $107.3K
Jun 05, 2025 Buy	Common stock M-Exempt	Thomas Steffen Director	Director	50 000 Value: $88.0K
Jun 05, 2025 Sell	Common stock F-InKind	Thomas Steffen Director	Director	11 349 Value: $88.0K
Jun 05, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Thomas Steffen Director	Director	50 000 Value: $88.0K
Jun 05, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Thomas Steffen Director	Director	50 000 Value: $88.0K
Jun 05, 2025 Sell	Common stock F-InKind	Thomas Steffen Director	Director	11 349 Value: $88.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ANAVEX LIFE SCIENCES CORP.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica...

Read Full Profile Here